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We developed an approach to geometry-guided repeat protein design (Fig. 2 ) that is implemented in the Rosetta molecular modelling package 22 and builds on published de novo design methodologies 23 . Key features include symmetry of backbone and side chain conformations extended across all repeats (allowing computational complexity to scale with repeat length rather than protein length); a pseudo-energy term that favours the desired inter-repeat geometry; clustering and resampling stages that allow intensified exploration of promising topologies; and an in silico validation step that assesses sequence-structure compatibility by attempting to re-predict the designed structure given only the designed sequence. Applying this design procedure produced a diverse array of toroidal structures (Fig. 2 ). We focused primarily on designs with left-handed bundles (Extended Data Fig. 1 ) since this architecture (closed, left-handed α -solenoid) appears to be absent from the structural database (Supplementary Discussion). We selected five monomeric repeat architectures for experimental characterization: a left-handed 3-repeat family (dTor_3x33L designed toroid with three 33-residue repeats, left-handed), left-and right-handed 6-repeat families (dTor_6x35L and dTor_6x33R), a left-handed 9-repeat family (dTor_9x31L), and a left-handed 12-repeat design built by extending one of the 9-repeat designs by three repeats (dTor_12x31L). To enhance the likelihood of successful expression, purification, and crystallization, we pursued multiple designed sequences for some families, including a round of surface mutants for three designs that were refractory to crystallization (Extended Data Table 1 ).
We were able to determine five crystal structures for representatives from four monomeric designed toroid families ( Fig. 3 , Extended Data Fig. 2 and Extended Data Table 2 ). Close examination of the electron density for the structures, during and after refinement, indicated that most of these highly symmetrical designed proteins display significant rotational averaging within the crystal lattice (Extended Data Fig. 3 ), such that the positions corresponding to the loops that 1 Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, Washington 98109, USA. 2 Letter reSeArCH connect each repeated module are occupied by a mixture of continuous peptide and protein termini. This lattice behaviour was observed for most of the structures, but only appeared to significantly affect the refinement R-factors for a final multimeric construct (described below) consisting of multiple copies of the first three repeats of dTor_9x31L. In all cases, however, the positions and conformations of secondary structure and individual side chains, which are largely invariant from one repeat to the next, were clear and unambiguous in the respective density maps. Ref. 24 describes similar crystal averaging with associated disorder at protein termini in a set of structures for designed consensus tetratricopeptide repeat (TPR) proteins, albeit with translational averaging along a fibre axis rather than the rotational averaging observed here.
Comparison of the design models with the experimental crystal structures shows that all four designs form left-handed α-helical toroids with the intended geometries. The structural deviation between design model and experimental structure increases with increasing repeat number: from 0.6 Å for the 3-repeat design, to 0.9 Å for the 6-repeat design, to 1.1 Å for the 9-and 12-repeat designs. Inspection of the superpositions in Fig. 3 suggests that the design models are slightly more compact than the experimental structures, a discrepancy which becomes more noticeable as the number of repeats increases. This trend may reflect a tendency of the current design procedure to over-pack side chains during the sequence optimization step (perhaps owing to under-weighting of repulsive electrostatic or van der Waals interactions). Nevertheless, the success of the 12x31L design implies that, at least for certain repeat modules, it is possible to control the geometry of the central pore by simply varying the number of repeats, without the need to re-optimize the sequence of individual repeats. Further characterization by size-exclusion chromatography indicated that the 3-and 6-repeat designs form stable dimers in solution while the 9-and 12-repeat designs form monomers; all are thermostable (Extended Data Table 1 and Extended Data Figs 4-6). Their behaviour did not vary significantly as a function of protein or salt concentration, nor did they display a dynamic equilibrium between monomeric and dimeric states.
Our ability to successfully design several left-handed α -toroids demonstrates that the apparent absence of this fold from the current database of solved structures is not due to constraints imposed by the helical solenoid architecture or the toroidal geometry. It is possible that there exist in nature left-handed α -toroids whose folds have not been observed; it is also possible that this region of fold space has not been sampled during natural protein evolution. Indeed, left-handed α -helical tandem repeat bundles of any kind-open or closed-are rare relative to their right-handed counterparts (which are found in TPR, Armadillo, HEAT, PUF, and PPR structures, among others). Our search for left-handed helical solenoid repeats with multiple turns in the structural database yielded only the TAL effector 6, 7 and mTERF 25 DNA binding domains (Supplementary Discussion). The handedness of our designed toroids is due in part to the use of inter-helical turns whose geometry naturally imparts a handedness to the resulting helical bundle. The three-residue 'GBB' 
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(α L -β -β ) turn type used in these designs prefers a left-handed dihedral twist between the connected helices, while the 'GB' turn found in dTor_6x33R correlates with right-handed geometry (Extended Data Fig. 1 ). Both of these turn types are also compatible with canonical helix capping interactions 26, 27 , which may explain their selection by the design procedure (helix capping guarantees satisfaction of backbone polar groups and also strengthens sequence-encoding of local structure). We explored the feasibility of splitting one of the larger monomeric designs into fragments that can assemble symmetrically to reform complete toroids comprising multiple copies of identical subunits. We selected the structurally characterized 9x31L design to split into a small 3-repeat subfragment, which was expected to then form a trimeric assembly. This 3-repeat fragment was expressed, purified, and formed diffraction-quality crystals. Upon determination of the experimental structure, we discovered that the design fragment formed an unexpected crystal packing arrangement composed of linked tetrameric rings (that is, containing a total of 12 repeats per ring; Fig. 4a ). Indeed, it was this unanticipated finding that led us to synthesize the monomeric 12x31L design whose characterization demonstrated that the designed 31-residue repeat sequence is compatible with both 9-and 12-repeat monomeric toroidal geometries (and presumably 10-and 11-repeat geometries as well). The crystal structure of the 3-repeat fragment suggests that the 12x geometry may be preferred, and indeed this would be consistent with the apparent tendency of our design procedure to over-pack the design models.
We expect that designed α -toroids may have potential applications as scaffolds for binding and catalysis and as building blocks for higher-order assemblies. Amino acids lining the central pores could be mutated to introduce binding or catalytic functionalities and/or sites of chemical modification. The modular symmetry of monomeric toroids could be exploited to array interaction surfaces with prescribed geometries: a designed interface on the external face of the 12x31L design, for example, could be replicated with two-, three-, four-, or six-fold symmetry by repeating the interfacial mutations throughout the full sequence. Thus monomeric toroids could replace multimeric assemblies as symmetry centres in the assembly of protein cages; by breaking the symmetry of the interaction surfaces it may be possible to create more complex heterotypic assemblies with non-uniform placement of functional sites. Examination of the crystalline arrangements formed by our designed toroids suggests the potential for creating specific one-and two-dimensional assemblies: both the monomeric 9x31L and 12x31L crystals have channels extending continuously through the crystal formed from the pores in vertical stacks of toroids (Fig. 4b, c) , with two-dimensional layers of toroids running perpendicular to these stacks. Interface design could be applied to stabilize the crystal contacts seen in the existing structures thereby further stabilizing either the crystalline state or these one-or two-dimensional sub-assemblies 28, 29 . Designed toroids with larger pores that crystallize in a similar manner might form crystal structures with channels capable of hosting guest molecules by covalent linkage or noncovalent binding. Stabilization of the concatemeric structure (Fig. 4a ) formed by the 3-repeat fragment either by cross-linking or interface design could represent a path towards a variety of novel protein-based materials 30 . 

MethODS
Computational design. The repeat module design process applied here consisted of an initial diversification round of large-scale sampling followed by filtering and clustering and then a second intensification round of sampling focused on successful topologies identified in the first round. Fragment assembly. Starting backbone models for sequence design were built using a fragment assembly protocol which is based on the standard Rosetta ab initio protocol 31 with the following modifications: (1) fragment replacement moves were performed symmetrically across all repeats, guaranteeing that backbone torsion angles were identical at corresponding positions across repeats; (2) a pseudoenergy term (equal to the deviation between actual and desired curvature, in degrees, plus the deviation in rise multiplied by a factor of 5) was added to the potential to favour satisfaction of the geometric constraints; (3) the aminoacid sequence used for low-resolution scoring was assigned randomly at the start of each simulation from secondary-structure-specific distributions (helix: Ala+Ile+Leu+Asp+Ser; turn: Gly+Ser), which had the effect of increasing the diversity in helix packing distances and geometries compared with using a constant sequence such as poly-Val or poly-Leu. At the start of each independent design trajectory, the lengths of the secondary structure elements and turns were chosen randomly, defining the target secondary structure of the repeat module and its length. Together with the number of repeats, this defined the total length of the protein and the complete secondary structure, which was used to select 3-and 9-residue backbone fragments for use in the low-resolution fragment assembly phase. The design calculations reported here sampled helix lengths from 7 to 20 residues, turn lengths from 1 to 5 residues, and total repeat lengths ranging from 20 to 40 residues. Sequence design. The low-resolution fragment assembly simulation was followed by an all-atom sequence design stage consisting of two cycles alternating between fixed-backbone sequence design and fixed-sequence structure relaxation. Symmetry of backbone and side-chain torsion angles and sequence identities was maintained across all repeats. Since the starting backbones for design were built by relatively coarse sampling in a low-resolution potential, sequences designed with the standard all-atom potential were dominated by small amino acids and the resulting structures tended to be under-packed. To correct for this tendency, a softened Lennard-Jones potential 32 was used for the sequence design steps, while the standard potential was used during the relaxation step. The Rosetta score12prime weights set was used as the standard potential for these design calculations. Filtering and clustering. Final design models (typically 10,000-100,000 in this study) were first sorted by per-residue energy (total energy divided by the number of residues, to account for varying repeat length) and the top 20% filtered for packing quality (sasapack_score <0.5), satisfaction of buried polar groups (buried unsatisfied donors per repeat <1.5, buried unsatisfied acceptors per repeat <0.5), and sequence-structure compatibility via a fast, low-resolution symmetric refolding test (40 trajectories, requiring at least 1 under an r.m.s.d. threshold of 2 Å for 3-repeat designs and 4 Å for larger designs). Designs that passed these filters were clustered by C-α r.m.s.d. (allowing for register shifts when aligning helices with unequal lengths) to identify recurring architectures. The clusters were ranked by averaging residue energy, packing quality, and refolding success over all cluster members.
Resampling. During the intensification round of designs, representative topologies from successful design clusters were specifically resampled by enforcing their helix and turn lengths as well as their turn conformations (defined using a fivestate, coarse-grained backbone torsion alphabet 27 ; Extended Data Fig. 1e ) during fragment selection. Large-scale refolding. Selected low-energy designs from the second round that pass the filters described above were evaluated by a large-scale refolding test in which 2,000-10,000 ab initio models were built by standard (asymmetric) fragment assembly followed by all-atom relaxation. Success was measured by assessing the fraction of low-energy ab initio models with r.m.s.d. values to the design model under a length-dependent threshold. Symmetry-breaking in the central pore. For designed toroids with an open, polar central pore, perfect symmetry may not allow optimal electrostatic interactions between nearby side chains corresponding to the same repeat position in successive repeats. We therefore explored symmetry-breaking mutations at a handful of inward-pointing positions via fixed-backbone sequence design simulations in which the length of the repeating sequence unit was doubled/tripled (for example, whereas perfect six-fold repeat symmetry would require K-K-K-K-K-K or E-E-E-E-E-E, doubling the repeat length allows charge complementarity with K-E-K-E-K-E). Solutions from these designs were accepted if they significantly lowered the total energy. Design model for dTor_12x31L. The 12x31L design construct was generated by duplicating the final three repeats of the 9x31L design. To build a 'design model' for comparison with the experimentally determined structure, we followed the resampling protocol now forcing the 12x31L amino-acid sequence in addition to the number of repeats (12) and the helix and turn lengths (H14-L3-H11-L3) and turn conformations (GBB). Thus the sequence design steps were reduced to rotamer optimization (since the amino-acid identities were fixed). This symmetric structure prediction process was repeated 10,000 times and the lowest-energy final model was taken as the computational model. Surface mutations to enhance crystallization. For a single representative of the 3x31L and 6x31R families, we performed lattice docking and design simulations to select mutations that might promote crystallization. Core positions were frozen at the design sequence. Candidate space groups were selected from those most commonly observed in the protein structural database. Theoretical models of crystal packing arrangements were built by randomly orienting the design model within the unit cell and reducing the lattice dimensions until clashes were encountered. Symmetric interface design was performed on these docked arrangements, and final designs were filtered by energy, packing, satisfaction of polar groups, and number of mutations from the original design model.
Handedness of tandem repeat helical bundles.
To compute the handedness of helical bundles formed by tandem repeat proteins, we generated an approximate helical bundle axis curve by joining the location of repeat-unit centres of mass in a sliding fashion along the protein chain. The handedness was then estimated by computing the directionality of the winding of the polypeptide chain about this axis curve. Structural bioinformatics. To assess similarity between design models and proteins in the structural database, we performed searches using the structurestructure comparison program DALI 33 as well as consulting the protein structure classification databases CATH 34 , SCOPe 35 , and ECOD 36 . Further details are given in Supplementary Discussion. Code availability. Repeat protein design methods were implemented in the Rosetta software suite (www.rosettacommons.org) and will be made freely available to academic users; licenses for commercial use are available through the University of Washington Technology Transfer office.
Cloning and protein expression. The plasmids encoding individual constructs were cloned into previously described bacterial pET15HE expression vectors 37 containing a cleavable N-terminal His-tag and an ampicillin resistance cassette. Sequence-verified plasmids were transformed into BL21(DE3)RIL Escherichia coli cells (Agilent Technologies) and plated on lysogeny broth (LB) medium with ampicillin (100 μ g ml −1 ). Colonies were individually picked and transferred to individual 10 ml aliquots of LB-ampicillin media and shaken overnight at 37 °C. Individual 10 ml aliquots of overnight cell cultures were added to individual 1 l volumes of LB-ampicillin, which were then shaken at 37 °C until the cells reached an absorbance at 600 nm of 0.6-0.8. The cells were chilled for 20 min at 4 °C, then isopropyl-β-d-thiogalactoside (IPTG) was then added to each flask to a final concentration of 0.5 mM to induce protein expression. The flasks were shaken overnight at 16 °C, and then pelleted by centrifugation and stored at − 20 °C until purification. Construct dTor_6x35L(SeMet), incorporating a single methionine residue at position 168 in the original design construct, was generated using a QuikChange site-directed mutagenesis kit (Agilent) and corresponding protocol from the vendor. The resulting plasmid construct was again transformed into BL21(DE3)RIL E. coli cells (Agilent Technologies) and plated on LB plates containing ampicillin (100 μ g ml −1 ) and chloramphenicol (35 g ml −1 ). Subsequent cell culture and protein expression in minimal media, along with incorporation of selenomethionine, was incorporated during protein expression according to ref. 38 . Purification. Cell pellets from 3 l of cell culture were resuspended in 60 ml of PBS solution (140 mM NaCl, 2.5 mM KCl, 10 mM NaHPO 4 , 2 mM KH 2 PO 4 ) containing 10 mM imidazole (pH 8.0). Cells were lysed via sonication and centrifuged to remove cell debris. The supernatant was passed through a 0.2 μ m filter, and then incubated on a rocker platform at 4 °C for 1 h after adding 3 ml of resuspended nickel-NTA metal affinity resin (Invitrogen). After loading onto a gravity-fed column, the resin was washed with 45 ml of the same lysis buffer described above, and the protein was eluted from the column with three consecutive aliquots of PBS containing 150 mM imidazole (pH 8.0). Purified protein was concentrated to approximately 5-25 mg ml −1 while buffer exchanging into 25 mM Tris (pH 7.5) and 200 mM NaCl and then further purified via size-exclusion chromatography using HiLoad 16/60 Superdex 200 column (GE).
Protein samples were then split in half; one sample was used directly for crystallization while the other had the His tag removed by an overnight digest with biotinylated thrombin (Novagen), before additional crystallization trials. The digested sample was incubated for 30 min with streptavidin-conjugated agarose (Novagen) to remove the thrombin. All samples were tested for purity and removal of the His tag via SDS-polyacrylamide gel electrophoresis. The final protein samples, both with and without the N-terminal poly-histidine affinity tag, were concentrated to values of 5-25 mg ml −1 for crystallization trials.
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Solution size and stability analysis. Proteins at a concentration of 4-10 mg ml −1 were run over a Superdex 75 10/300 GL column (GE Healthcare) in 25 mM Tris pH 8.0 plus 100 or 750 mM NaCl at a rate of 0.4 ml min −1 on an AKTAprime plus chromatography system (GE Healthcare). All fractions containing eluted toroid protein (visualized via electrophoretic gel analyses) were pooled, concentrated, and run over the column a second time to assess their solution oligomeric behaviour using protein with a minimal background of contaminants. Gel filtration standards (Bio-Rad) were run over the same column in matching buffer, and the ultraviolet trace of the proteins was overlaid onto the standards using UNICORN 5 software (GE Healthcare).
For measurements of protein stability using circular dichroism spectroscopy, purified recombinant toroid constructs were diluted to between 10 and 20 μ M concentration and dialysed overnight into 10 mM potassium phosphate buffer at pH 8.0. Circular dichroism thermal denaturation experiments were performed on a JASCO J-815 circular dichroism spectrometer with a Peltier thermostat. Wavelength scans (190-250 nm) were performed for each construct at 20 °C and 95 °C. Additional thermal denaturation experiments were conducted by monitoring circular dichroism signal strength at 206 nm over a temperature range of 4-95 °C (0.1 cm path-length cell), with measurements taken every 2°. Sample temperature was allowed to equilibrate for 30 s before each measurement. Crystallization and data collection. Purified proteins were initially tested for crystallization via sparse matrix screens in 96-well sitting drops using a mosquito (TTP LabTech). Crystallization conditions were then optimized with constructs that proved capable of crystallizing in larger 24-well hanging drops. Out of 11 constructs that were purified to homogeneity, 10 were crystallized, of which 5 yielded high quality X-ray diffraction that resulted in successful structure determination.
dTor_6x35L was crystallized in 160 mM sodium chloride, 100 mM Bis-Tris pH 8.5 and 24% (w/v) polyethylene glycol 3350 at a concentration of 26 mg ml −1 . The crystal was transferred to a solution containing 300 mM, then 500 mM sodium chloride and flash frozen in liquid nitrogen. Data were collected on a R-AXIS IV+ + at wavelength 1.54 Å and processed on an HKL2000 (ref. 39 ). dTor_6x35L(SeMet) was crystallized in 140 mM sodium chloride, 100 mM Tris pH 8.5 and 22% (w/v) polyethylene glycol 3350 at a concentration of 26 mg ml −1 . The crystal was transferred to a solution containing 300 mM, then 500 mM sodium chloride and flash frozen in liquid nitrogen. Data were collected at ALS Beamline 5.0.2 at wavelength 0.9794 Å and processed on an HKL2000 (ref. 39 ).
dTor_3x33L_2-2 was crystallized in two different conditions, producing two different crystal lattices. The first condition had 30% polyethylene glycol 3350, 100 mM Tris pH 6.5, 200 mM NaCl with a protein concentration of 1.8 mM. The protein was soaked in a 15% ethylene glycol cryoprotectant for 1 min before being flash frozen in liquid nitrogen. Data were collected on a Saturn 944+ (Rigaku) at wavelength 1.54 Å for 180° at ϕ = 0 and another 180° at ϕ = 180. Data were then processed on an HKL2000 (ref. 39) out to 1.85 Å in space group P2 1 2 1 2 1 .
The second condition had 45% polyethylene glycol 400 and 100 mM Tris pH 7.7 with a protein concentration of 1.8 mM. Protein crystal was flash frozen without being cryoprotected. Data were collected on a Saturn 944+ (Rigaku) at wavelength 1.54 Å for 180° at ϕ = 0 and another 180° at phi = 180. Data were then processed on an HKL2000 (ref. 39) out to 1.85Å in space group P4 3 2 1 2.
dTor_9x31L_sub was crystallized in 100 mM Tris pH 8.5 and 15% (v/v) ethanol at a concentration of 11.5 mg ml −1 . The crystal was transferred to a solution containing 75 mM Tris pH 8.5, 7.5% (v/v) ethanol and 25% (v/v) glycerol and flash frozen in liquid nitrogen. Data were collected at ALS Beamline 5.0.2 at wavelength 1.0 Å and processed on an HKL2000 (ref. 39) out to 2.9 Å in space group P4 1 2 1 2/P4 3 2 1 2.
dTor_9x31L was crystallized in 0.1 M sodium citrate pH 5.4 and 1.0 M ammonium phosphate monobasic at a concentration of 8.8 mg ml −1 in 3 μ l drops containing 1 μ l protein and 2 μ l well solution. The crystal was transferred to a solution containing the well plus 25% (v/v) glycerol and flash frozen in liquid nitrogen. Data were collected on a Saturn 944+ charge-coupled device at wavelength 1.54 Å and processed on an HKL2000 (ref. 39) out to 2.5 Å in space group P2 1 2 1 2 1 .
dTor_12x31L was crystallized in 0.9 M sodium malonate pH 7.0, 0.1 M HEPES pH 7.0 and 0.5% Jeffamine ED-2001 pH 7.0 at a concentration of 8.8 mg ml −1 in 2 μ l drops containing 1 μ l protein and 1 μ l well solution. The crystal was transferred to a solution containing 0.675 M sodium malonate pH 7.0, 0.075 M HEPES pH 7.0, 0.375% Jeffamine ED-2001 pH 7.0 and 25% glycerol, and flash frozen in liquid nitrogen. Data were collected on a Saturn 944+ charge-coupled device at wavelength 1.54 Å and processed on an HKL2000 (ref. 39) out to 2.3 Å in space group R3:H. Phasing and refinement. The dTor_6x35L and both dTor_3x33L_2-2 structures were solved by Molecular Replacement with Phaser 40 via CCP4i 41 using the Rosetta-designed structure as a search model. The structures were then built and refined using Coot 42 and Refmac5 43 , respectively.
The structure of dTor_6x35L(SeMet) was solved by Molecular Replacement with Phaser 40 via PHENIX 44 using the best refined model of dTor_6x35L as a phasing model. The structure was then built and refined using Coot 42 and PHENIX 45 , respectively.
The structures of dTor_9x31L_sub and dTor_9x31L were solved by Molecular Replacement with Phaser 40 via PHENIX 44 using the Rosetta-designed structure as a search model. The structure was then built and refined using Coot 42 and PHENIX 45 , respectively.
The structure of dTor_12x31L was solved by Molecular Replacement with Phaser 40 via PHENIX 44 using a 4-repeat subunit the Rosetta-designed structure as a search model. The structure was then built and refined using Coot 42 and PHENIX 45 , respectively.
Final Ramachandran statistics after refinement were as follows (given as % preferred, % allowed, % outliers, respectively): dTor_6x35L(SeMet): 98.06, 1.94, 0.0; dTor_3x33L_2-2a: 99.48, 0.0, 0.52; dTor_3x33L_2-2b: 98.96, 0.52, 0.52; dTor_9x31L_sub: 98.31, 1.69, 0.0; dTor_9x31L: 99.28, 0.36, 0.36; dTor_12x31L: 99.0, 1.0, 0.0.
Extended Data Figure 6 | Potential dimerization interfaces observed in crystal packing interactions. a, Superposition of monomer-monomer packing interactions for the dTor_3x33L_2-2 design observed in two entirely different crystal forms. b, Stacking interactions between two dTor_6x35L subunits observed in the crystal structure; lysine residues interacting with backbone carbonyl groups in the partner monomer are shown in stick representation and coloured yellow along with their interaction partners.
extended Data table 2 | Crystallographic statistics * Each structure was determined from a single crystal.
†Highest resolution shell is shown in parenthesis.
